Kaori Kuramitsu

1.3k total citations · 1 hit paper
65 papers, 850 citations indexed

About

Kaori Kuramitsu is a scholar working on Hepatology, Surgery and Oncology. According to data from OpenAlex, Kaori Kuramitsu has authored 65 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hepatology, 37 papers in Surgery and 26 papers in Oncology. Recurrent topics in Kaori Kuramitsu's work include Hepatocellular Carcinoma Treatment and Prognosis (26 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers) and Pancreatic and Hepatic Oncology Research (17 papers). Kaori Kuramitsu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (26 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers) and Pancreatic and Hepatic Oncology Research (17 papers). Kaori Kuramitsu collaborates with scholars based in Japan, United States and South Korea. Kaori Kuramitsu's co-authors include Yury Popov, Deanna Sverdlov, Takumi Fukumoto, Masahiro Kido, Kahini A. Vaid, Michelle Lai, Linlin Wei, Shuangshuang Zhao, Makoto Miyamoto and Ping An and has published in prestigious journals such as Nature Communications, Hepatology and American Journal Of Pathology.

In The Last Decade

Kaori Kuramitsu

61 papers receiving 847 citations

Hit Papers

Hepatocyte mitochondria-derived danger signals directly a... 2020 2026 2022 2024 2020 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaori Kuramitsu Japan 13 518 342 317 161 130 65 850
Yuki Bekki Japan 17 530 1.0× 362 1.1× 440 1.4× 106 0.7× 125 1.0× 62 870
Ulrich Töx Germany 16 284 0.5× 346 1.0× 233 0.7× 158 1.0× 111 0.9× 34 749
Sun Young Yim South Korea 18 472 0.9× 457 1.3× 160 0.5× 223 1.4× 88 0.7× 74 977
Weiqiang Ju China 17 400 0.8× 261 0.8× 411 1.3× 249 1.5× 113 0.9× 74 948
Sarah Raevens Belgium 19 460 0.9× 410 1.2× 347 1.1× 137 0.9× 54 0.4× 51 857
Rebecca Brais United Kingdom 15 555 1.1× 312 0.9× 716 2.3× 83 0.5× 201 1.5× 40 1.1k
Chung-Bao Hsieh Taiwan 17 289 0.6× 173 0.5× 260 0.8× 159 1.0× 120 0.9× 52 687
Edward Mena United States 14 364 0.7× 471 1.4× 123 0.4× 122 0.8× 79 0.6× 28 696
Sang Jun Suh South Korea 17 646 1.2× 596 1.7× 246 0.8× 197 1.2× 102 0.8× 50 1.1k

Countries citing papers authored by Kaori Kuramitsu

Since Specialization
Citations

This map shows the geographic impact of Kaori Kuramitsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaori Kuramitsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaori Kuramitsu more than expected).

Fields of papers citing papers by Kaori Kuramitsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaori Kuramitsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaori Kuramitsu. The network helps show where Kaori Kuramitsu may publish in the future.

Co-authorship network of co-authors of Kaori Kuramitsu

This figure shows the co-authorship network connecting the top 25 collaborators of Kaori Kuramitsu. A scholar is included among the top collaborators of Kaori Kuramitsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaori Kuramitsu. Kaori Kuramitsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yanagimoto, Hiroaki, Daisuke Tsugawa, Masayuki Akita, et al.. (2023). Prognostic Impact of Malnutrition Diagnosed by the GLIM Criteria for Resected Extrahepatic Cholangiocarcinoma. Anticancer Research. 43(5). 2299–2308. 2 indexed citations
2.
Kuramitsu, Kaori, Masahiro Kido, Shohei Komatsu, et al.. (2023). Factors Predicting Over-Time Weight Increase After Liver Transplantation: A Retrospective Study. Transplantation Proceedings. 55(4). 924–929.
3.
Kuramitsu, Kaori, et al.. (2023). Investigation of Changes in Skeletal Muscle Mass and Muscle Quality and Factors Affecting Changes in Deceased Donor Liver Transplantation. Transplantation Proceedings. 55(7). 1649–1655. 1 indexed citations
4.
Ishida, Jun, Hirochika Toyama, Sadaki Asari, et al.. (2022). Use of a short cartridge stapler is beneficial in pancreatic transection at the neck during laparoscopic distal pancreatectomy. Surgery Today. 53(1). 153–157. 1 indexed citations
5.
Kuramitsu, Kaori, Ryosuke Osawa, Takashi Kenmochi, et al.. (2022). Impact of COVID‐19 on living donor liver and kidney transplantation programs in Japan in 2020. Transplant Infectious Disease. 24(3). e13845–e13845. 2 indexed citations
6.
Komatsu, Shohei, Kazuomi Ueshima, Masahiro Kido, et al.. (2022). Hepatectomy versus sorafenib for advanced hepatocellular carcinoma with macroscopic portal vein tumor thrombus: A bi‐institutional propensity‐matched cohort study. Journal of Hepato-Biliary-Pancreatic Sciences. 30(3). 303–314. 8 indexed citations
7.
Urade, Takeshi, Masahiro Kido, Kaori Kuramitsu, et al.. (2022). Standardization of laparoscopic anatomic liver resection of segment 2 by the Glissonean approach. Surgical Endoscopy. 36(11). 8600–8606. 5 indexed citations
8.
Komatsu, Shohei, Yoshihiko Yano, Jun Ishida, et al.. (2022). Current Role of Atezolizumab Plus Bevacizumab Therapy in the Sequential Treatment of Unresectable Hepatocellular Carcinoma. Anticancer Research. 42(3). 1403–1412. 6 indexed citations
9.
Yanagimoto, Hiroaki, Tetsuo Ajiki, Daisuke Tsugawa, et al.. (2022). Prognostic Impact of Inflammation-Based Scores for Extrahepatic Cholangiocarcinoma. Digestive Surgery. 39(2-3). 65–74. 9 indexed citations
10.
An, Ping, Linlin Wei, Shuangshuang Zhao, et al.. (2020). Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis. Nature Communications. 11(1). 2362–2362. 228 indexed citations breakdown →
11.
Komatsu, Shohei, Yoshihiko Yano, Keitaro Sofue, et al.. (2020). Assessment of lenvatinib treatment for unresectable hepatocellular carcinoma with liver cirrhosis. HPB. 22(10). 1450–1456. 12 indexed citations
12.
Gon, Hidetoshi, Shohei Komatsu, Masahiro Kido, et al.. (2019). Real-time navigation during hepatectomy using fusion indocyanine green-fluorescence imaging: protocol for a prospective cohort study. BMJ Open. 9(8). e030233–e030233. 6 indexed citations
15.
Kuramitsu, Kaori, Takumi Fukumoto, Masahiro Kido, et al.. (2016). A Case Report of Drug-Induced Thrombocytopenia after Living Donor Liver Transplantation.. PubMed. 62(1). E9–E12. 6 indexed citations
16.
Tsugawa, Daisuke, Takumi Fukumoto, Masahiro Kido, et al.. (2015). The Predictive Power of Serum α-Fetoprotein and Des-γ-Carboxy Prothrombin for Survival Varies by Tumor Size in Hepatocellular Carcinoma.. PubMed. 61(5). E124–31. 4 indexed citations
17.
Ishida, Jun, Ippei Matsumoto, Makoto Shinzeki, et al.. (2014). Repeated limited resections for pancreatic metastases from renal cell carcinoma. Suizo. 29(2). 247–252. 1 indexed citations
18.
Kuramitsu, Kaori, Takumi Fukumoto, Takeshi Iwasaki, et al.. (2014). Long-term Complications After Liver Transplantation. Transplantation Proceedings. 46(3). 797–803. 9 indexed citations
19.
Yano, Yoshihiko, Takumi Fukumoto, Atsushi Takebe, et al.. (2013). Quantification of Pregenomic RNA and Covalently Closed Circular DNA in Hepatitis B Virus-Related Hepatocellular Carcinoma. International Journal of Hepatology. 2013. 1–9. 25 indexed citations
20.
Fukumoto, Takumi, Masahiro Kido, Masanori Takahashi, et al.. (2012). Novel Non-Trocar Technique for Laparoscopic Radiofrequency Ablation. Digestive Diseases. 30(6). 588–591. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026